GSK Investigational Site

Fresno, California 93720

Use our guide to learn which trials are right for you!

We've found
2 trials
at this facility
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis (ASCEND-TD)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Fresno, CA
Click here to add this to my saved trials
Anaemia Clinical Trial
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Fresno, CA
Click here to add this to my saved trials